PARP inhibitors and their evolving role for the treatment of prostate cancer
PARP inhibitors and their evolving role for the treatment of prostate cancer
OncoAlert and ecancer weekly roundup for September 14-19, 2020
Latest updates to the ESMO bone health guidelines
Estimate of the 2-year oncology workload generated by each new patient: A real-world study
MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer
Personalised molecularly matched therapies for carcinomas of unknown primary
OncoAlert and ecancer weekly roundup for August 30 - September 5 2020
Overtreatment and surgery on the axilla
Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research
OncoAlert and ecancer weekly roundup for August 1-8 2020
Direction and reasoning behind the AORTIC African Cancer Dialogues
Epidemiology of gastric cancer